Healthcare Services

Global Long‑Read Sequencing Services Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Long‑Read Sequencing Services Market At The End Of The 2026–2030 Forecast Period?

The long-read sequencing services market has demonstrated significant growth in recent years. This market is expected to expand from $1.18 billion in 2025 to $1.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.9%. The historical expansion of this market can be attributed to progress in sequencing chemistry and instruments, increased financial support for genomics research, a growing need for high-resolution genome analysis, the broadening of academic genomics projects, and the presence of specialized sequencing service providers.

The long-read sequencing services market size is poised for significant expansion in the coming years. It is forecast to grow to $2.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. This anticipated growth during the forecast period is fueled by several factors, including the growing clinical acceptance of long-read sequencing, increased investments in population genomics, the broadening of precision oncology research, a rising need for de novo genome assembly, and the integration of AI-based genomic interpretation. Key trends expected in the forecast period encompass an escalating demand for structural variant analysis services, the increasing adoption of nanopore sequencing platforms, the expanding application of long-read sequencing in rare disease research, the proliferation of clinical-grade long-read sequencing services, and an enhanced emphasis on comprehensive genome assembly.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28260&type=smp

What Primary Drivers Are Shaping The Development Of The Long‑Read Sequencing Services Market?

The increasing incidence of genetic disorders is anticipated to drive the expansion of the long-read sequencing services market moving forward. Genetic diseases are conditions resulting from modifications or mutations in DNA, which can be either inherited or occur spontaneously, thereby impacting health, development, or various bodily functions. The rising frequency of genetic diseases is attributable to heightened awareness and advancements in diagnostic technologies, which enable earlier and more accurate detection of conditions that were previously undiagnosed. Long-read sequencing services facilitate the management of genetic disorders by supplying highly accurate, comprehensive genomic data, enabling precise identification of structural variants and complex mutations. For instance, in April 2024, the National Institutes of Health (NIH), a US-based government’s premier biomedical research agency, reported that an estimated 6.9 million Americans aged 65 and older are currently living with Alzheimer’s dementia, with this figure projected to nearly double to 13.8 million by 2060. Therefore, the growing prevalence of genetic disorders is propelling the growth of the long-read sequencing services market.

What Segment Types Make Up The Long‑Read Sequencing Services Market?

The long‑read sequencing services market covered in this report is segmented –

1) By Service Type: Whole Genome Sequencing, Targeted Sequencing, De Novo Sequencing, Other Services

2) By Technology: Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies

3) By Application: Clinical Diagnostics, Genomic Research, Oncology, Rare Disease Detection, Other Applications

4) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Whole Genome Sequencing: Complete Genome Mapping, Comprehensive Variant Detection, Structural Variation Analysis, Comparative Genomics

2) By Targeted Sequencing: Gene Panel Sequencing, Exome Sequencing, Transcriptome Sequencing, Custom Target Region Sequencing

3) By De Novo Sequencing: Novel Genome Assembly, Structural Variant Characterization, Complex Genome Reconstruction, Non-Model Organism Sequencing

4) By Other Services: Data Analysis And Interpretation, Library Preparation Services, Bioinformatics Support Services, Validation And Quality Control Services

Which Upcoming Trends Are Expected To Influence The Long‑Read Sequencing Services Market?

Leading companies in the long-read sequencing services market are prioritizing the creation of advanced solutions, such as primary template directed amplification (PTA), which enables high-fidelity, uniform whole-genome amplification from single cells and facilitates the sensitive detection of single-nucleotide variants (SNVs). Primary template-directed amplification is a proprietary whole-genome amplification technique developed to precisely and uniformly amplify deoxyribonucleic acid (DNA) from ultra-low input samples, thereby reducing errors and maintaining the original deoxyribonucleic acid (DNA) sequence. Highlighting this advancement, in October 2025, BioSkryb Genomics, Inc., a US-based genomics company specializing in long-read sequencing technologies, unveiled the ResolveSEQ LongRead Early Access Program. This platform represents a state-of-the-art single-cell whole-genome long-read sequencing solution that integrates primary template-directed amplification (PTA) with long-read library preparation to deliver high-coverage, uniform amplification from individual cells. Additionally, the platform supports the sensitive detection of single-nucleotide variants (SNVs) and repeat expansions, while also providing haplotype phasing at single-cell resolution.

Who Are The Key Players Driving Competition In The Long‑Read Sequencing Services Market?

Major companies operating in the long‑read sequencing services market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., Macrogen Inc., Novogene Co. Ltd., DNAnexus Inc., Zymo Research Corp., CD Genomics Inc., Genotypic Technology Pvt. Ltd., Plasmidsaurus Inc., BaseClear B.V., GrandOmics Biosciences Co. Ltd., Arima Genomics Inc., Wuhan Benagen Technology Co. Ltd.

Read the full long‑read sequencing services market report here:

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-services-global-market-report

How Does The Long‑Read Sequencing Services Market Perform Across Major Global Regions?

North America was the largest region in the long‑read sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long‑read sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Long‑Read Sequencing Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28260&type=smp

Browse Through More Reports Similar to the Global Long‑Read Sequencing Services Market 2026, By The Business Research Company

Anti Parkinson Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

Regenerative Medicine Market

https://www.thebusinessresearchcompany.com/report/regenerative-medicine-market

Dermatophytosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/dermatophytosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795